Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT PX ?3.4 x 14.0: medical device reports filed with FDA

363 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

363
device reports naming the brand
0% of all MAUDE reports · about 67 a year
91
reports, 12 months to August 2026
63 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 363 reports that name the brand "AXIOM IMPLANT PX ?3.4 x 14.0" (endosseous dental implant), received between February 2021 and August 2026; the manufacturer given most often on reports is Anthogyr. Spellings of one product vary from report to report.

91 reports arrived in the 12 months to August 2026, up 44% from 63 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (81%), loss of osseointegration (14.9%) and difficult to insert (0.3%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01019Sep 2021: 0Oct 2021: 4Nov 2021: 2Dec 2021: 62022Jan 2022: 8Feb 2022: 6Mar 2022: 2Apr 2022: 0May 2022: 6Jun 2022: 3Jul 2022: 9Aug 2022: 10Sep 2022: 4Oct 2022: 1Nov 2022: 9Dec 2022: 52023Jan 2023: 2Feb 2023: 4Mar 2023: 3Apr 2023: 1May 2023: 1Jun 2023: 10Jul 2023: 7Aug 2023: 2Sep 2023: 10Oct 2023: 3Nov 2023: 6Dec 2023: 92024Jan 2024: 8Feb 2024: 1Mar 2024: 7Apr 2024: 5May 2024: 5Jun 2024: 5Jul 2024: 1Aug 2024: 5Sep 2024: 1Oct 2024: 2Nov 2024: 2Dec 2024: 32025Jan 2025: 1Feb 2025: 5Mar 2025: 10Apr 2025: 2May 2025: 0Jun 2025: 19Jul 2025: 9Aug 2025: 9Sep 2025: 12Oct 2025: 5Nov 2025: 8Dec 2025: 82026Jan 2026: 8Feb 2026: 6Mar 2026: 5Apr 2026: 13May 2026: 2Jun 2026: 11Jul 2026: 6Aug 2026: 7

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

044882021: 5120212022: 6320222023: 5820232024: 4520242025: 8820252026: 582026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%363
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%363
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate29481%62.8%
Loss of osseointegration5414.9%22.4%
Difficult to insertthe device was hard to insert10.3%0.4%
Fracturea broken bone10.3%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis6517.9%
Painpain, site not specified236.3%
Inflammationinflammation215.8%
Swelling/ edema174.7%
Hypersensitivity/allergic reaction61.7%
Hemorrhage/blood loss/bleeding41.1%
Abscessa collection of pus30.8%
Fistula30.8%
Hyperresponsive to stimuli30.8%
Numbnessnumbness20.6%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT PX ?3.4 x 14.0Product code DZEAll MAUDE reports
Reports3633,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT PX ?3.4 x 14.0 reports

How many FDA reports name AXIOM IMPLANT PX ?3.4 x 14.0?

363 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 91 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (81%), loss of osseointegration (14.9%), difficult to insert (0.3%) and fracture (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT PX ?3.4 x 14.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.